BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith continues its investigation on behalf of Ekso Bionics Holdings, Inc. (“Ekso” or the “Company”) (NASDAQ: EKSO) investors concerning the Company and its officers’ possible violations of federal securities laws.
On December 14, 2017, the Company disclosed that its internal control over financial reporting was materially weak as of December 31, 2016, and that the Company’s representations regarding the effectiveness of its internal controls as of that date should no longer be relied upon.
Then, on December 27, 2017 the Company filed amended quarterly and annual reports for the periods: FY 2016, Q1 2017, Q2 2017, and Q3 2017. Over the course of these disclosures, the Company’s share price declined, thereby injuring investors.
If you purchased Ekso securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to firstname.lastname@example.org, or visit our website at www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.